Vibrant Therapeutics ("Vibrant"), a clinical-stage biotechnology company developing next-generation intelligent therapeutics, today announced $61 million in new financing. The financing includes new ...
Inc.) (the "Company" or "Definium") unveiled its new brand today, marking a decisive step forward as the company leads psychiatry toward a transformation built on strong clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback